Nurse Practitioner Gabriela Huyke prepares for medical examination of a volunteer for a coronavirus vaccine study.Moderna said its experimental coronavirus vaccine helps prevent COVID-19.It's a big victory in the fight against the pandemic, but the data hasn't been published in a peer-reviewed journal, and regulators haven't reviewed the vaccine.We just took another big step forward in fighting the coronavirus pandemic.
There's a lot to keep in mind about what the results mean for the pandemic and for when Americans might be able to get a shot now that two vaccines have proven successful.As of Moderna's initial analysis of its late-stage, 30,000-person trial, its vaccine is 94.5% effective. Pfizer reported that its vaccine was more than 90% effective.
Having two effective vaccines, however, should help increase distribution. Moncef Slaoui, the head of Operation Warp Speed,Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, on Sunday The pandemic is raging across the US with surges in new cases, hospitalizations, and deaths. The shots are still experimental and the process to authorize a shot will likely take weeks, Peter Marks, the FDA's director of the Center for Biologics Evaluation and Research, told Business Insider in a November 13 interview.
"That's just the price we going to have to pay to play our role so that we minimize the risk of contamination and we protect those who are at highest risk," Bancel said in a Sunday evening interview.Moderna's vaccine won't require a deep-freeze, unlike Pfizer's shot.
90% of news about covid and trump